Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers
Clinical trial NCT01412281 · COMPLETED
Trial details
- NCT number
- NCT01412281
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2011-12-01
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.